EPA Versus Mixed EPA/DHA Plus Statin for Coronary Atherosclerosis: Meta-Analysis of Prospective Imaging Trials

JACC Cardiovasc Imaging. 2022 Oct;15(10):1825-1828. doi: 10.1016/j.jcmg.2022.04.014. Epub 2022 Jun 15.
No abstract available

Publication types

  • Letter
  • Meta-Analysis

MeSH terms

  • Coronary Artery Disease* / diagnostic imaging
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors* / adverse effects
  • Predictive Value of Tests
  • Prospective Studies

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors